Allied Market Research
Loading...
0
New
New
2021
Healthcare Analytics Market

Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Analysis and Clinical Analysis), Component (Hardware, Software and Services), Deployment Model (On-Premise and On-Demand), End User (Healthcare Payers, Healthcare Providers and Others), and Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics): Global Opportunity Analysis and Industry Forecast, 2021–2030

A07488
Pages: 308
Aug 2021 | 1761 Views
   
Author(s) : Pramod Borasi, Shadaab Khan , Vineet Kumar
Tables: 163
Charts: 74
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Healthcare Analytics Market

Request Now !

Healthcare Analytics Market Statistics- 2030

The global healthcare analytics market size was valued at $23.51 billion in 2020, and is projected to reach $96.90 billion by 2030, growing at a CAGR of 15.3% from 2021 to 2030. Healthcare analytics allows healthcare professionals to find opportunities to improve operations, patient engagement, care delivery, and clinical outcomes. Healthcare data analytics combines real-time and historical data to predict trends, reveal actionable insights, achieve medical advances, and drive long-term growth. In addition to this, healthcare analytics solutions uses vast amounts of collected data to provide organizations with actionable insights. 

The healthcare analytics industry attained significant growth during the COVID-19 pandemic, owing to increase in need for deployment of analytics solution among healthcare organizations for managing different complexities and to support healthcare organization during critical situation in the pandemic situation. In addition to this, enormous amount of data generated during the pandemic has given researchers and healthcare providers the opportunity to analyse trends, monitor patient populations, and begin to rectify longstanding issues in the healthcare industry, which is driving the growth of the market.

Rise in adoption of big data in healthcare organizations and surge in government initiatives to increase the adoption of electronic health records (EHRs) among healthcare organizations boost the growth of the healthcare analytics market. In addition, pressure among the healthcare organizations to curb the unnecessary expenses positively impacts the growth of the market. However, factors such as high implementation cost and lack of skilled labors is expected to hamper the healthcare analytics market growth. On the contrary, use of cloud-based analytics across various healthcare providers and rise in adoption of augmented analytics among the healthcare industry is expected to offer remunerative opportunities for the expansion of the market during the forecast period.

Healthcare-Analytics-Market

Get more information on this report : Request Sample Pages

By deployment model, the on-premise segment garnered the largest healthcare analytics share and is expected to maintain its dominance in the upcoming years as on-premise software is considered widely useful in large enterprises as software can be implemented on IT infrastructure of a company itself and it provides more security as compared to on-demand. However, the on-demand segment is expected to witness highest growth, owing to a paradigm shift in deployment methods from on-premise to on-demand models. In addition, leading market vendors of healthcare analytics have introduced strategies to help enterprises move their on-premise healthcare analytics to on-demand models, which further fuels the growth of the segment.

Region wise, the healthcare analytics was dominated by North America in 2020, and is expected to retain its position during the forecast period. This is attributed to growing federal healthcare mandates to curb the rising healthcare cost and rising government initiatives focusing on personalized medicine. However, Asia-Pacific is expected to witness significant growth during the forecast period, owing to growing e-health initiatives in developing nations of Asia-Pacific and growing need of analytics solution among healthcare organizations for managing large amount of patient’s data set.

The report focuses on growth prospects, restraints, and trends of the global healthcare analytics market analysis. The study provides Porter’s five forces analysis to understand impact of various factors, such as bargaining power of suppliers, competitive intensity of competitors, threat of new entrants, threat of substitutes, and bargaining power of buyers, on the global healthcare analytics market share.

Segment review

The global healthcare analytics market is segmented on the basis of application, component, deployment model, end user, type and region. Depending on application, it is fragmented into financial analysis, operational & administrative analysis and clinical analysis. By component, the market is categorized into hardware software and services. By deployment model, it is bifurcated as on-premise and on-demand. As per end user, the market is categorized into, healthcare payers, healthcare providers and others. On the basis of type, it is classified into descriptive analytics, predictive analytics, and prescriptive analytics. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Healthcare Analytics Market
By Application

Your browser does not support the canvas element.

Financial Analysis segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

The key players profiled in the healthcare analytics market analysis are Allscript Healthcare Solution, Cerner Corporation, Health Catalyst, HMS(Vitreoshealth), IBM Corporation, McKesson Corporation, MedeAnalytics, Inc., Oracle Corporation, Optum, Inc., and SAS, Institute. These players have adopted various strategies to increase their market penetration and strengthen their position in the healthcare analytics industry.

Impact of COVID-19 on Healthcare Analytics Market

The COVID-19 pandemic has impacted all the industries globally. The healthcare analytics market is projected to prosper in the COVID-19 situation owing to growing adoption of healthcare analytics solution among the healthcare organization for managing large quantity of COVID-19 data. In addition to this, the main problem in COVID-19 pandemic was predicting the need of hospital staff; thus analytics solution helps organizations to manage the staff requirement accordingly and also helps in tracking the health of staff. Furthermore, various developing nations across the globe are adopting healthcare analytics solutions for fighting against the pandemic situation, which is driving the growth of the market. 

Healthcare Analytics Market
By Deployment Model

Your browser does not support the canvas element.

On-premise is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Top impacting factors

Rise in adoption of big data in healthcare organizations

Rise in adoption of big data in healthcare organizations for tackling various risks related to various different chronic diseases drives the growth of the market. In addition to this, growing adoption of telemedicine solutions among various enterprises for reducing the operational cost and to improve the quality of the services also propels the growth of the market. Furthermore, big data also helps to store patient critical information that can be used to improve the clinical outcomes of the organizations. It leverages the labor cost and increases the productivity of the organizations, which is also driving the growth of the market. Growing investment on workforce management tools, electronic health record, and practice solution by various healthcare solutions drives the growth of the market. 

Growing government initiatives to increase the adoption of electronic health records (EHRs) among healthcare organizations

Growing adoption of EHRs across various organizations for improving the accuracy of documentation and to track and implement preventive measures in the healthcare organizations drives the growth of the market. In addition to this, governments of various developing nations are mandating EHRs for healthcare organizations to improve the quality of the treatment for the patients, which propels the growth of the market. For instance, according to a survey conducted in the year 2019 by AHA’s Information Technology, in India approximately 68% of the healthcare organizations have used EHRs for identifying high risk patients and to provide proper treatment for the patients. In addition to this, EHRs also help patient to track their healthcare spending and gets a deep knowledge about the diseases, which is also increasing the demand for EHRs among the patient. For instance according to the recent Federal Rules updated in the year 2020 in the U.S., patients can access the data through EHRs and can also keep track of the data through their mobile phone. Thus, growing number of such developments across the globe is driving the growth of the market. 

Healthcare Analytics Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific would exhibit the highest CAGR of 19.4% during 2021-2030.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders     

  • The study provides an in-depth analysis of the global healthcare analytics market forecast along with the current trends and future estimations to explain the imminent investment pockets.
  • Information about key drivers, restraints, & opportunities and their impact analysis on the global market is provided in the report.
  • Porter’s five forces analysis illustrates the potency of the buyers and suppliers operating in the industry.
  • The quantitative analysis of the healthcare analytics market trends from 2021 to 2030 is provided to determine the market potential.

Key Market Segments

By Application

  • Financial Analysis
  • Operational & Administrative Analysis
  • Clinical Analysis

By Component

  • Hardware 
  • Software
  • Service

By Deployment

  • On-Premise
  • On-Demand

By End User

  • Healthcare Payers
  • Healthcare Providers
  • Other

By Type

  • Descriptive Analytics 
  • Predictive Analytics
  • Prescriptive Analytics

By Region

  • North America
    • U.S.
    • Canada
  • Europe 
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific 
    • China
    • Japan
    • South Korea
    • Australia
    • India    
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America 
    • Middle East 
    • Africa

Key Market Players

  • Allscript Healthcare Solution
  • Cerner Corporation
  • Health Catalyst
  • HMS (Vitreoshealth)
  • IBM Corporation
  • McKesson Corporation
  • MedeAnalytics Inc.
  • Oracle Corporation
  • Optum Inc.
  • SAS Institute 
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings

2.1.1.Top impacting factors
2.1.2.Top investment pockets

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key forces shaping the global Healthcare analytics market
3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in adoption of big data in healthcare organizations
3.3.1.2.Growing government initiatives to increase the adoption of electronic health records (EHRs) among healthcare organizations
3.3.1.3.Pressure among the healthcare organizations to curb the unnecessary expensive

3.3.2.Restraints

3.3.2.1.High Implementation cost
3.3.2.2.Lack of skilled labors

3.3.3.Opportunities

3.3.3.1.Use of cloud-based analytics across various healthcare providers

3.4.COVID-19 impact analysis on healthcare analytics market

3.4.1.Impact on market size
3.4.2.Consumer trends, preferences, and budget impact
3.4.3.Economic impact
3.4.4.Strategies to tackle negative impact
3.4.5.Opportunity window

CHAPTER 4:HEALTHCARE ANALYTICS MARKET, BY APPLICATION

4.1.Overview
4.2.Financial Analysis

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Operational & Administrative Analysis

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Clinical Analysis

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:HEALTHCARE ANALYTICS MARKET, BY COMPONENT

5.1.Overview
5.2.Hardware

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Software

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Service

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

CHAPTER 6:HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

6.1.Overview
6.2.On-premise

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.On-Demand

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

CHAPTER 7:HEALTHCARE ANALYTICS MARKET, BY END USER

7.1.Overview
7.2.Healthcare Payers

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market analysis, by country

7.3.Healthcare Providers

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market analysis, by country

7.4.Others

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market analysis, by country

CHAPTER 8:HEALTHCARE ANALYTICS MARKET, BY TYPE

8.1.Overview
8.2.Descriptive Analytics

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by region
8.2.3.Market analysis, by country

8.3.Predictive Analytics

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by region
8.3.3.Market analysis, by country

8.4.Prescriptive Analytics

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by region
8.4.3.Market analysis, by country

CHAPTER 9:HEALTHCARE ANALYTICS MARKET, BY REGION

9.1.Overview

9.1.1.Market size and forecast, by region

9.2.North America

9.2.1.Key market trends, growth factors, and opportunities
9.2.2.Market size and forecast, by application
9.2.3.Market size and forecast, by component
9.2.4.Market size and forecast, by deployment model
9.2.5.Market size and forecast, by traditional end user
9.2.6.Market size and forecast, by type
9.2.7.Market size and forecast, by country

9.2.7.1.U.S.

9.2.7.1.1.Market size and forecast, by application
9.2.7.1.2.Market size and forecast, by component
9.2.7.1.3.Market size and forecast, by deployment model
9.2.7.1.4.Market size and forecast, by traditional end user
9.2.7.1.5.Market size and forecast, by type

9.2.7.2.CANADA

9.2.7.2.1.Market size and forecast, by application
9.2.7.2.2.Market size and forecast, by component
9.2.7.2.3.Market size and forecast, by deployment model
9.2.7.2.4.Market size and forecast, by traditional end user
9.2.7.2.5.Market size and forecast, by type

9.3.Europe

9.3.1.Key market trends, growth factors, and opportunities
9.3.2.Market size and forecast, by application
9.3.3.Market size and forecast, by component
9.3.4.Market size and forecast, by deployment model
9.3.5.Market size and forecast, by traditional end user
9.3.6.Market size and forecast, by type
9.3.7.Market size and forecast, by country

9.3.7.1.UK

9.3.7.1.1.Market size and forecast, by application
9.3.7.1.2.Market size and forecast, by component
9.3.7.1.3.Market size and forecast, by deployment model
9.3.7.1.4.Market size and forecast, by traditional end user
9.3.7.1.5.Market size and forecast, by type

9.3.7.2.GERMANY

9.3.7.2.1.Market size and forecast, by application
9.3.7.2.2.Market size and forecast, by component
9.3.7.2.3.Market size and forecast, by deployment model
9.3.7.2.4.Market size and forecast, by traditional end user
9.3.7.2.5.Market size and forecast, by type

9.3.7.3.FRANCE

9.3.7.3.1.Market size and forecast, by application
9.3.7.3.2.Market size and forecast, by component
9.3.7.3.3.Market size and forecast, by deployment model
9.3.7.3.4.Market size and forecast, by traditional end user
9.3.7.3.5.Market size and forecast, by type

9.3.7.4.ITALY

9.3.7.4.1.Market size and forecast, by application
9.3.7.4.2.Market size and forecast, by component
9.3.7.4.3.Market size and forecast, by deployment model
9.3.7.4.4.Market size and forecast, by traditional end user
9.3.7.4.5.Market size and forecast, by type

9.3.7.5.SPAIN

9.3.7.5.1.Market size and forecast, by application
9.3.7.5.2.Market size and forecast, by component
9.3.7.5.3.Market size and forecast, by deployment model
9.3.7.5.4.Market size and forecast, by traditional end user
9.3.7.5.5.Market size and forecast, by type

9.3.7.6.NETHERLANDS

9.3.7.6.1.Market size and forecast, by application
9.3.7.6.2.Market size and forecast, by component
9.3.7.6.3.Market size and forecast, by deployment model
9.3.7.6.4.Market size and forecast, by traditional end user
9.3.7.6.5.Market size and forecast, by type

9.3.7.7.REST OF EUROPE

9.3.7.7.1.Market size and forecast, by application
9.3.7.7.2.Market size and forecast, by component
9.3.7.7.3.Market size and forecast, by deployment model
9.3.7.7.4.Market size and forecast, by traditional end user
9.3.7.7.5.Market size and forecast, by type

9.4.Asia-Pacific

9.4.1.Key market trends, growth factors, and opportunities
9.4.2.Market size and forecast, by application
9.4.3.Market size and forecast, by component
9.4.4.Market size and forecast, by deployment model
9.4.5.Market size and forecast, by traditional end user
9.4.6.Market size and forecast, by type
9.4.7.Market size and forecast, by country

9.4.7.1.CHINA

9.4.7.1.1.Market size and forecast, by application
9.4.7.1.2.Market size and forecast, by component
9.4.7.1.3.Market size and forecast, by deployment model
9.4.7.1.4.Market size and forecast, by traditional end user
9.4.7.1.5.Market size and forecast, by type

9.4.7.2.JAPAN

9.4.7.2.1.Market size and forecast, by application
9.4.7.2.2.Market size and forecast, by component
9.4.7.2.3.Market size and forecast, by deployment model
9.4.7.2.4.Market size and forecast, by traditional end user
9.4.7.2.5.Market size and forecast, by type

9.4.7.3.SOUTH KOREA

9.4.7.3.1.Market size and forecast, by application
9.4.7.3.2.Market size and forecast, by component
9.4.7.3.3.Market size and forecast, by deployment model
9.4.7.3.4.Market size and forecast, by traditional end user
9.4.7.3.5.Market size and forecast, by type

9.4.7.4.AUSTRALIA

9.4.7.4.1.Market size and forecast, by application
9.4.7.4.2.Market size and forecast, by component
9.4.7.4.3.Market size and forecast, by deployment model
9.4.7.4.4.Market size and forecast, by traditional end user
9.4.7.4.5.Market size and forecast, by type

9.4.7.5.INDIA

9.4.7.5.1.Market size and forecast, by application
9.4.7.5.2.Market size and forecast, by component
9.4.7.5.3.Market size and forecast, by deployment model
9.4.7.5.4.Market size and forecast, by traditional end user
9.4.7.5.5.Market size and forecast, by type

9.4.7.6.REST OF ASIA-PACIFIC

9.4.7.6.1.Market size and forecast, by application
9.4.7.6.2.Market size and forecast, by component
9.4.7.6.3.Market size and forecast, by deployment model
9.4.7.6.4.Market size and forecast, by traditional end user
9.4.7.6.5.Market size and forecast, by type

9.5.LAMEA

9.5.1.Key market trends, growth factors, and opportunities
9.5.2.Market size and forecast, by application
9.5.3.Market size and forecast, by component
9.5.4.Market size and forecast, by deployment model
9.5.5.Market size and forecast, by traditional end user
9.5.6.Market size and forecast, by type
9.5.7.Market size and forecast, by country

9.5.7.1.LATIN AMERICA

9.5.7.1.1.Market size and forecast, by application
9.5.7.1.2.Market size and forecast, by component
9.5.7.1.3.Market size and forecast, by deployment model
9.5.7.1.4.Market size and forecast, by traditional end user
9.5.7.1.5.Market size and forecast, by type

9.5.7.2.MIDDLE EAST

9.5.7.2.1.Market size and forecast, by application
9.5.7.2.2.Market size and forecast, by component
9.5.7.2.3.Market size and forecast, by deployment model
9.5.7.2.4.Market size and forecast, by traditional end user
9.5.7.2.5.Market size and forecast, by type

9.5.7.3.AFRICA

9.5.7.3.1.Market size and forecast, by application
9.5.7.3.2.Market size and forecast, by component
9.5.7.3.3.Market size and forecast, by deployment model
9.5.7.3.4.Market size and forecast, by traditional end user
9.5.7.3.5.Market size and forecast, by type

CHAPTER 10:COMPETITIVE LANDSCAPE

10.1.Key players positioning analysis, 2020
10.2.Competitive dashboard
10.3.Top winning strategies

CHAPTER 11:COMPANY PROFILE

11.1.ALLSCRIPTS HEALTHCARE, LLC

11.1.1.Company overview
11.1.2.Key executives
11.1.3.Company snapshot
11.1.4.Operating business segments
11.1.5.Product portfolio
11.1.6.R&D expenditure
11.1.7.Business performance
11.1.8.Key strategic moves and developments

11.2.Cerner Corporation

11.2.1.Company overview
11.2.2.Key Executives
11.2.3.Company snapshot
11.2.4.Product portfolio
11.2.5.Business performance
11.2.6.Key strategic moves and developments

11.3.HEALTH CATALYST

11.3.1.Company overview
11.3.2.Key executives
11.3.3.Company snapshot
11.3.4.Operating business segments
11.3.5.Product portfolio
11.3.6.R&D expenditure
11.3.7.Business performance
11.3.8.Key strategic moves and developments

11.4.HMS(VITREOSHEALTH)

11.4.1.Company overview
11.4.2.Key executive
11.4.3.Company snapshot
11.4.4.Product portfolio
11.4.5.Business performance

11.5.INTERNATIONAL BUSINESS MACHINES CORPORATION

11.5.1.Company overview
11.5.2.Key executive
11.5.3.Company snapshot
11.5.4.Operating business segments
11.5.5.Product portfolio
11.5.6.R&D expenditure
11.5.7.Business performance
11.5.8.Key strategic moves and developments

11.6.MCKESSON CORPORATION

11.6.1.Company overview
11.6.2.Key executives
11.6.3.Company snapshot
11.6.4.Operating business segments
11.6.5.Product portfolio
11.6.6.R&D expenditure
11.6.7.Business performance
11.6.8.Key strategic moves and developments

11.7.MEDEANALYTICS, INC.

11.7.1.Company overview
11.7.2.Key executives
11.7.3.Company snapshot
11.7.4.Product portfolio
11.7.5.Key strategic moves and developments

11.8.OPTUM, INC.

11.8.1.Company overview
11.8.2.Key executives
11.8.3.Company snapshot
11.8.4.Product portfolio

11.9.ORACLE CORPORATION

11.9.1.Company overview
11.9.2.Key Executives
11.9.3.Company snapshot
11.9.4.Operating business segments
11.9.5.Product portfolio
11.9.6.R&D Expenditure
11.9.7.Business performance
11.9.8.Key strategic moves and developments

11.10.SAS INSTITUTE INC.

11.10.1.Company overview
11.10.2.Key executive
11.10.3.Company snapshot
11.10.4.Product portfolio
11.10.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 02.HEALTHCARE ANALYTICS MARKET REVENUE FOR FINANCIAL ANALYSIS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYSIS, BY REGION 2020–2030 ($MILLION)
TABLE 04.HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYSIS, BY REGION 2020–2030 ($MILLION)
TABLE 05.HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 06.HEALTHCARE ANALYTICS MARKET REVENUE FOR HARDWARE, BY REGION, 2020–2030 ($MILLION)
TABLE 07.HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION 2020–2030 ($MILLION)
TABLE 08.HEALTHCARE ANALYTICS MARKET FOR SERVICE, BY REGION 2020–2030 ($MILLION)
TABLE 09.HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030($MILLION)
TABLE 10.HEALTHCARE ANALYTICS MARKET REVENUE FOR ON-PREMISE, BY REGION, 2020–2030 ($MILLION)
TABLE 11.HEALTHCARE ANALYTICS MARKET REVENUE FOR ON-DEMAND, BY REGION, 2020–2030 ($MILLION)
TABLE 12.HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 13.HEALTHCARE ANALYTICS MARKET REVENUE FOR HEALTHCARE PAYERS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.HEALTHCARE ANALYTICS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY REGION, 2020–2030 ($MILLION)
TABLE 15.HEALTHCARE ANALYTICS MARKET REVENUE FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 16.HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030($MILLION)
TABLE 17.HEALTHCARE ANALYTICS MARKET REVENUE FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 18.HEALTHCARE ANALYTICS MARKET REVENUE FOR PREDICTIVE ANALYTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 19.HEALTHCARE ANALYTICS MARKET REVENUE FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 20.HEALTHCARE ANALYTICS MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 21.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 22.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 23.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 24.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 27.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 28.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 29.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 30.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 31.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 32.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 34.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 35.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 36.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 37.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 39.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 40.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 41.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 42.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 43.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 45.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 46.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 47.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 48.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 50.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 51.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 52.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 53.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 55.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 56.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 57.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 58.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 59.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 60.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 61.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 62.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 63.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 65.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 66.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 67.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 68.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 70.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 71.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 72.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 73.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 74.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 75.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 76.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 77.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 78.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 80.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 81.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 82.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 83.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 84.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 86.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 87.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 88.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 89.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 90.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 91.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 92.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 93.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 94.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 95.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 96.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 97.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 98.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 99.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 100.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 101.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 102.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 103.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 104.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 105.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 106.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 107.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 108.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 109.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 110.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 111.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 112.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 113.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 114.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 115.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 116.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 117.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 118.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 119.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 120.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 121.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 122.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 123.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 124.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 125.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 126.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 127.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 128.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 129.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 130.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 131.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 132.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 133.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 134.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 135.ALLSCRIPTS HEALTHCARE, LLC: KEY EXECUTIVE
TABLE 136.ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT
TABLE 137.ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS
TABLE 138.ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO
TABLE 139.CERNER CORPORATION: KEY EXECUTIVES
TABLE 140.CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 141.CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 142.HEALTH CATALYST: KEY EXECUTIVE
TABLE 143.HEALTH CATALYST: COMPANY SNAPSHOT
TABLE 144.HEALTH CATALYST: OPERATING SEGMENTS
TABLE 145.HEALTH CATALYST: PRODUCT PORTFOLIO
TABLE 146.HMS(VITREOSHEALTH): KEY EXECUTIVE
TABLE 147.HMS(VITREOSHEALTH): COMPANY SNAPSHOT
TABLE 148.HMS(VITREOSHEALTH): PRODUCT PORTFOLIO
TABLE 149.INTERNATIONAL BUSINESS MACHINES CORPORATION: KEY EXECUTIVE
TABLE 150.INTERNATIONAL BUSINESS MACHINES CORPORATION: COMPANY SNAPSHOT
TABLE 151.INTERNATIONAL BUSINESS MACHINES CORPORATION: OPERATING SEGMENTS
TABLE 152.INTERNATIONAL BUSINESS MACHINES CORPORATION: PRODUCT PORTFOLIO
TABLE 153.MCKESSON CORPORATION.: KEY EXECUTIVES
TABLE 154.MCKESSON CORPORATION : COMPANY SNAPSHOT
TABLE 155.MCKESSON CORPORATION: OPERATING SEGMENTS
TABLE 156.MCKESSON CORPORATION: PRODUCT PORTFOLIO
TABLE 157.MEDEANALYTICS, INC.: KEY EXECUTIVES
TABLE 158.MEDEANALYTICS, INC.: COMPANY SNAPSHOT
TABLE 159.MEDEANALYTICS, INC.: PRODUCT PORTFOLIO
TABLE 160.OPTUM, INC.: KEY EXECUTIVES
TABLE 161.OPTUM, INC.: COMPANY SNAPSHOT
TABLE 162.OPTUM, INC.: PRODUCT PORTFOLIO
TABLE 163.ORACLE CORPORATION: KEY EXECUTIVES
TABLE 164.ORACLE CORPORATION: COMPANY SNAPSHOT
TABLE 165.ORACLE CORPORATION: OPERATING SEGMENTS
TABLE 166.ORACLE CORPORATION: PRODUCT PORTFOLIO
TABLE 167.ORACLE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 168.SAS INSTITUTE INC.: KEY EXECUTIVE
TABLE 169.SAS INSTITUTE INC.: COMPANY SNAPSHOT
TABLE 170.SAS INSTITUTE INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.HEALTHCARE ANALYTICS MARKET SNAPSHOT, BY SEGMENTATION, 2020–2030
FIGURE 03.HEALTHCARE ANALYTICS MARKET SNAPSHOT, BY COUNTRY, 2020–2030
FIGURE 04.TOP IMPACTING FACTORS
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.MODERATE -TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE-TO-HIGH BARGAINING POWER OF BUYER
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE-TO-HIGH COMPETITIVE RIVALRY
FIGURE 11.HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYSIS, BY COUNTRY, 2020 & 2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYSIS, BY COUNTRY, 2020 & 2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYSIS, BY COUNTRY, 2020 & 2030(%)
FIGURE 15.HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR HARDWARE, BY COUNTRY, 2020 & 2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY COUNTRY, 2020 & 2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY COUNTRY, 2020 & 2030(%)
FIGURE 19.HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2030
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE, BY COUNTRY, 2020 & 2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND, BY COUNTRY, 2020 & 2030 (%)
FIGURE 22.HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2030
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020 & 2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020 & 2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 26.HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2030
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR DESCRIPTIVE ANALYTICS, BY COUNTRY, 2020 & 2030(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR PREDICTIVE ANALYTICS, BY COUNTRY, 2020 & 2030(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR PRESCRIPTIVE ANALYTICS, BY COUNTRY, 2020 & 2030(%)
FIGURE 30.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 31.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 32.UK HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 33.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 34.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 35.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 36.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 37.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 38.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 39.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 40.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 41.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 42.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 43.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 44.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 45.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 46.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 47.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 48.KEY PLAYER POSITIONING ANLYSIS: GLOBAL HEALTHCARE ANALYTICS MARKET
FIGURE 49.COMPETITIVE DASHBOARD
FIGURE 50.COMPETITIVE DASHBOARD
FIGURE 51.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 52.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 53.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 54.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 55.R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 56.ALLSCRIPTS HEALTHCARE, LLC: REVENUE, 2018–2020 ($MILLION)
FIGURE 57.ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 58.ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 59.CERNER CORPORATION: REVENUE, 2018–2020 ($MILLION)
FIGURE 60.R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 61.HEALTH CATALYST: REVENUE, 2018–2020 ($MILLION)
FIGURE 62.HEALTH CATALYST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 63.HMS(VITREOSHEALTH): REVENUE, 2018–2020 ($MILLION)
FIGURE 64.R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 65.INTERNATIONAL BUSINESS MACHINES CORPORATION: REVENUE, 2018–2020 ($MILLION)
FIGURE 66.INTERNATIONAL BUSINESS MACHINES CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 67.INTERNATIONAL BUSINESS MACHINES CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 68.R&D EXPENDITURE, 2019–2021 ($MILLION)
FIGURE 69.MCKESSON CORPORATION: REVENUE, 2019–2021 ($MILLION)
FIGURE 70.MCKESSON CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 71.R&D EXPENDITURE, 2019–2021 ($MILLION)
FIGURE 72.ORACLE CORPORATION: REVENUE, 2019–2021 ($MILLION)
FIGURE 73.ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 74.ORACLE CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

 
 

Adoption of healthcare analytics solutions has increased among the healthcare organizations over the years to identify the individuals who are at greater risk and to provide proper treatment for the individuals. In addition to this, various governments across the globe are rapidly using healthcare analytics for fighting the COVID-19 pandemic and to provide better treatment facilities for their people. Furthermore, the healthcare analytics solution helps hospitals to provide individuals with remote consultations as well as to monitor health status of the individual which is driving the growth of the market.

Key providers of healthcare analytics market such as Allscript Healthcare Solution, Cerner Corporation, Health Catalyst, IBM Corporation, McKesson Corporation, MedeAnalytics, Inc. and Oracle Corporation, account for a significant share in the market. For instance, in December 2020, Cerner acquired Kantar Health, which is a sub part of Kantar Group, is mainly engaged in handling real-time data, analytics and other thing. With this acquisition, Cerner plans to harness data to improve the safety, efficiency and efficacy of clinical research across life sciences, pharmaceuticals and healthcare. This acquisition strategy is expected to enhance its service offering and increase its market revenue. According to the industry experts, the healthcare analytics market is expected to witness increased adoption in the coming years, owing to digital transformation in industries and rapid adoption of IoT among various sectors. North America is expected to dominate the market during the forecast period, while emerging countries in Asia-Pacific and Latin America are projected to offer significant growth opportunities.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Healthcare Analytics Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,713
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,126
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,169
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,930
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,665
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers